Journey Medical Corporation (DERM)

NASDAQ: DERM · Real-Time Price · USD

5.96

-0.25 (-4.03%)

At close: May 22, 2026, 4:00 PM EDT

6.00

+0.04 (0.67%)

After-hours: May 22, 2026, 5:31 PM EDT

Journey Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	27.22	24.09	20.31	27.44	32	49.08
Cash & Short-Term Investments	27.22	24.09	20.31	27.44	32	49.08
Cash Growth	29.18%	18.64%	-26.00%	-14.26%	-34.80%	495.21%
Accounts Receivable	24.99	29.78	10.23	15.22	28.21	23.11
Inventory	9.29	9.62	14.43	10.21	14.16	9.86
Other Current Assets	3.46	3.38	3.21	3.59	3.31	2.44
Total Current Assets	64.97	66.87	48.18	56.46	77.68	84.49
Net Property, Plant & Equipment	0.09	0.11	0.2	0.1	0.19	0.09
Other Intangible Assets	26.48	27.61	31.86	20.29	27.2	12.55
Other Long-Term Assets	-	-	-	0.01	0.1	0.15
Total Assets	91.53	94.59	80.24	76.85	105.16	97.28
Accounts Payable	8.67	9.31	16.58	18.34	36.98	23.45
Accrued Expenses	26.49	27.97	17.83	20.37	19.55	22.73
Short-Term Debt	-	-	-	-	2.95	0.81
Current Portion of Long-Term Debt	2.5	-	-	-	-	-
Current Portion of Leases	0.09	0.1	0.08	0.1	0.08	0.1
Other Current Liabilities	0.07	0.07	0.69	3.05	7.27	4.52
Total Current Liabilities	37.83	37.44	35.18	41.87	66.83	51.61
Long-Term Debt	22.87	25.28	24.88	14.62	19.83	-
Long-Term Leases	-	0.02	0.12	0.01	0.11	-
Other Long-Term Liabilities	-	-	-	-	1.41	3.63
Total Long-Term Liabilities	22.87	25.3	25	14.63	21.35	3.63
Total Liabilities	60.7	62.74	60.17	56.5	88.18	55.24
Common Stock	0	0	0	0	0	0
Additional Paid-in Capital	131.52	130.31	107.09	92.7	85.48	80.92
Retained Earnings	-100.69	-98.46	-87.03	-72.36	-68.5	-38.87
Shareholders' Equity	30.83	31.85	20.07	20.35	16.98	42.04
Total Liabilities & Equity	91.53	94.59	80.24	76.85	105.16	97.28
Total Debt	25.47	25.4	25.08	14.73	22.97	0.91
Net Cash (Debt)	1.75	-1.31	-4.78	12.71	9.04	48.17
Net Cash Growth	-	-	-	40.62%	-81.24%	1593.78%
Net Cash Per Share	0.07	-0.05	-0.23	0.70	0.52	4.73
Book Value	30.83	31.85	20.07	20.35	16.98	42.04
Book Value Per Share	1.20	1.30	0.98	1.12	0.97	4.13
Tangible Book Value	4.35	4.25	-11.79	0.06	-10.22	29.49
Tangible Book Value Per Share	0.17	0.17	-0.58	0.00	-0.58	2.90

Updated May 13, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q